Skin biopsy is the cornerstone diagnostic tool of dermatology; about 1–2% require follow-up for complications such as infection; overall safety is high."Biopsy spreads cancer" is a common myth — evidence does not support this risk; on the contrary,skipping biopsy delays diagnosis. In skin tumor excision surgery, correct fusiform design with a 3:1 length-to-width ratio, apex angle ≤30°, and long axis parallel to Langer's tension lines is the key to cosmetically acceptable scars (Bode 2026). Wound infection rate is about 1–3% (Mahoney 2026). Routine antibiotic prophylaxis is not recommended; reserve antibiotics for high-risk patients or sites (skin flap, diabetes, immunosuppression, prosthetic joint, etc.).
Biopsy vs excision
Biopsy: take tissue for histopathology; may take part (incisional) or all (excisional) of a lesion. Excision: remove the entire lesion plus margin for treatment ± diagnosis. All removed tissue should be sent to pathology.
Eight indications for biopsy (UpToDate, Alguire 2026)
- Suspected neoplastic / malignant lesions
- Bullous disorders (DIF for pemphigus/pemphigoid)
- Hair disorders (scarring vs nonscarring)
- Confirm clinical diagnosis when treatment fails
- Atypical presentation
- Broad clinical differential diagnosis
- Microbiologic culture (deep mycoses, mycobacteria, leishmaniasis)
- Unexpected poor response to therapy
Myth-buster: "Biopsy spreads cancer" — not supported by evidence (Martin 2005, JAMA Dermatol). Delayed biopsy is what worsens prognosis.
The 4 skin biopsy techniques
- Shave: superficial, 15-blade or razor; for elevated lesions (SK, intradermal nevus, BCC). Hemostasis with cautery or aluminum chloride; no suture.
- Punch (3-8 mm): full-thickness cylinder; for inflammatory dermatoses, deep neoplasms; ≤ 3 mm may not require suture, ≥ 4 mm 1-2 sutures.
- Incisional: fusiform sample of larger lesion (> 1.5 cm); preserves normal-skin reference; sutured.
- Excisional: complete fusiform with 1-3 mm margin; standard for suspected melanoma.
Anesthesia: lidocaine 1-2% with epinephrine 1:100,000 (max 7 mg/kg); 27-30 G needle, slow injection; bicarbonate buffering reduces pain.
Nail biopsy — the most challenging
Indications: melanonychia striata with red flags (width ≥ 3 mm, irregular pigment, single digit, adult-onset, Hutchinson sign, growth/dystrophy/bleeding), persistent dystrophy refractory to topicals, primary nail tumors. Three techniques: 3 mm punch of nail bed (no permanent dystrophy); tangential matrix shave biopsy (preserves matrix function — preferred for melanonychia ≥ 3 mm); longitudinal elliptical excision (lateral nail unit, full-thickness, may permanently narrow nail). Mandatory: digital block, finger tourniquet; warn about pigment recurrence and partial nail dystrophy.
Common benign lesions
Acquired melanocytic nevus, seborrheic keratosis, skin tag, lipoma, dermatofibroma, cherry angioma, xanthelasma. Each has typical clues; biopsy/excision when ABCDE features or ugly-duckling sign.
ABCDE + Ugly Duckling
Asymmetry, Border irregularity, Color variation, Diameter > 6 mm, Evolution. Ugly-duckling sign (one nevus that looks unlike the others) is more sensitive than ABCDE for melanoma.
Fusiform excision workflow
3:1 length:width, apex angles ≤ 30°, long axis parallel to relaxed skin tension lines (RSTL/Langer). Anticoagulants generally NOT stopped (Mahoney 2026). Incision perpendicular to skin, undermine 5-10 mm, electrocautery hemostasis, two-layer closure (deep absorbable + epidermal nonabsorbable), pressure dressing 24-48 h.
Other destructive options
Cryotherapy, curettage + electrodesiccation, CO₂/Er:YAG laser, intralesional triamcinolone, pulsed dye laser. Cryotherapy and laser destroy tissue and cannot evaluate margins — use only for clinically certain benign lesions.
Post-op care — including the bathing controversy
Pressure dressing for 24-48 h. Suture removal: face 5-7 d, scalp/trunk/upper limb 7-10 d, lower limb/back 10-14 d, joints 14-21 d. Continue Steri-Strip support 2-4 weeks after suture removal.
Bathing — the evidence: Traditional advice is "no water until sutures are out, use waterproof dressing." Heal CF et al. BMJ 2006 RCT (n=857) showed 8.4% vs 8.9% infection rate between early-wetting (12 h post-op) and 48-h-dry groups — no significant difference. Cochrane 2015 (Toon) supports early bathing safety. Practical advice: keep the pressure dressing 24-48 h, then brief lukewarm shower (no soaking), pat dry, re-apply petrolatum. Follow your surgeon's specific instructions for high-risk wounds.
Infection vs normal redness: normal peaks 24-72 h, redness within 2-3 mm of edge, mild warmth, decreasing pain. Infection appears 4-7 days later, spreading erythema > 1 cm, increasing pain, purulent discharge, fever. Routine antibiotic prophylaxis NOT recommended; reserved for high-risk sites (lower extremity, ear, lip, genitalia), immunocompromise, prosthetic joints (Mahoney 2026).
Sun protection x 6-12 months is the most effective scar care. Silicone gel/sheets 12 h/d for 2-3 months reduces scar thickness. Keloid prone areas (earlobe, shoulder, chest, family history): post-op intralesional triamcinolone 10-40 mg/mL every 4-6 weeks × 3.
"Spitting sutures": 4-12 weeks post-op, small white bumps may emerge — buried absorbable suture extruding, not infection; gentle removal in clinic.
Bottom line
Skin biopsy and excision are routine, safe procedures. Four principles: appropriate indications (ABCDE/ugly-duckling), correct technique (depth, fusiform geometry, RSTL alignment), evidence-based wound care (early wetting safe at 48 h, lifelong sun protection), and routine pathology submission.